Peripheral rotavirus-specific T-cell responses following monovalent oral rotavirus vaccine in infants
npj Vaccines, 2026
Nicols A., Lee Y., Congrave-Wilson Z., Kim M., Cheng W., Jumarang J., Navarro J., Navarro R., Rodriguez-Angeles Y., Durand D., Taylor Z., De León R., Ochoa T., Sette A., da Silva Antunes R., Pannaraj P.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Infectious Diseases | Pathophysiology | Serum | Olink Target 48 |
Abstract
Despite evidence of varying vaccine effectiveness, T cell responses to rotavirus (RV) vaccines remain incompletely studied. To address this research gap, RV-specific T cells in the blood of infants pre- and post-monovalent RV vaccination (RV1) were analyzed for memory recall and functionality using RV-specific peptide pool stimulation. We find that RV vaccine elicits heterogenous responses with respect to cellular and humoral immunity. T cell responses to RV vaccine are detectable in the periphery, though poorly functional. Vaccination induces Th2-biased conventional effector memory and central memory CD4 + T cells, as suggested by chemokine receptor profiles, though the response wanes by 8 months post vaccination. The presence of preexisting immunity results in no significant increase in either RV-specific IgA or T cells after vaccination. Our data provides the first in-depth assessment of RV-specific T cell responses induced by vaccine, demonstrating patterns of negative and positive association with response that may play a role in protection against rotavirus disease.